文献速递血液净化与透析

加拿大与美国透析治疗的卫生政策对比

Health Policy for Dialysis Care in Canada and the United States.
PubMed 文献 · Clin J Am Soc Nephrol · 2020-06-25

本文对比了加拿大和美国在透析治疗上的卫生政策差异。美国透析主要由政府资助但由私立营利机构提供,加拿大则由政府资助且几乎完全由公立机构提供。政策差异与临床结局相关,加拿大透析患者死亡率持续低于美国,但近年差距缩小。

要点

  • 加拿大透析患者死亡率持续低于美国,但差距近年缩小。
  • 美国透析以私立营利机构为主,加拿大以公立机构为主。
  • 支付、财务、监管和组织是影响透析实践的关键政策杠杆。

核心结论

  • 美加透析政策差异与临床结局差异相关,加拿大死亡率更低但差距缩小。
  • 两国卫生系统可相互借鉴政策经验以改善透析护理。

研究设计与样本

  • 本文为跨国卫生政策比较分析,聚焦支付、财务、监管和组织等政策杠杆。

主要发现

  • 美国透析主要由政府资助、私立营利机构提供;加拿大由政府资助、公立机构提供。
  • 加拿大透析患者死亡率持续低于美国,但近年差距缩小。
  • 监管机制和政策激励在两国间存在差异,可能影响提供者和机构行为。

临床怎么用

  • 政策杠杆可激励有利的实践模式,支持高质量、高价值、以人为中心的护理。
  • 政策设计可催化替代肾脏替代策略的变革性技术的出现。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Contemporary dialysis treatment for chronic kidney failure is complex, is associated with poor clinical outcomes, and leads to high health costs, all of which pose substantial policy challenges. Despite similar policy goals and universal access for their kidney failure programs, the United States and Canada have taken very different approaches to dealing with these challenges. While US dialysis care is primarily government funded and delivered predominantly by private for-profit providers, Canadian dialysis care is also government funded but delivered almost exclusively in public facilities. Differences also exist for regulatory mechanisms and the policy incentives that may influence the behavior of providers and facilities. These differences in health policy are associated with significant variation in clinical outcomes: mortality among patients on dialysis is consistently lower in Canada than in the United States, although the gap has narrowed in recent years. The observed heterogeneity in policy and outcomes offers important potential opportunities for each health system to learn from the other. This article compares and contrasts transnational dialysis-related health policies, focusing on key levers including payment, finance, regulation, and organization. We also describe how policy levers can incentivize favorable practice patterns to support high-quality/high-value, person-centered care and to catalyze the emergence of transformative technologies for alternative kidney replacement strategies.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Tonelli M, Vanholder R, Himmelfarb J, et al. Health Policy for Dialysis Care in Canada and the United States. Clin J Am Soc Nephrol. 2020. PMID: 32586926. doi:10.2215/CJN.14961219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。